Australia markets closed

Takeda Pharmaceutical Company Limited (TAK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
18.18-0.19 (-1.03%)
At close: 4:00PM EST

18.05 -0.14 (-0.77%)
Before hours: 7:35AM EST

Full screen
Trade prices are not sourced from all markets
Previous close18.37
Open18.54
Bid0.00 x 1200
Ask0.00 x 1400
Day's range18.16 - 18.54
52-week range12.43 - 20.42
Volume9,045,387
Avg. volume2,500,285
Market cap56.98B
Beta (5Y monthly)1.09
PE ratio (TTM)22.40
EPS (TTM)0.81
Earnings dateN/A
Forward dividend & yield0.85 (4.67%)
Ex-dividend date29 Sep 2020
1y target est23.54
  • Takeda Achieved Carbon Neutrality in 2020
    Business Wire

    Takeda Achieved Carbon Neutrality in 2020

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it achieved carbon neutrality in its value chain for its fiscal year 2019. This achievement was delivered by a continued focus on internal energy conservation measures, procurement of green energy, and investment in renewable energy certificates and high-quality, verified carbon offsets. These actions collectively address 100 percent of Takeda’s fiscal year 2019 scope 1, 2, and 3 emissions1 and represent a significant milestone in Takeda’s sustainability journey.

  • Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
    Business Wire

    Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three technical areas evaluated by the Index, including being ranked first in Governance of Access. Takeda also demonstrated strong performance in the areas of health system strengthening, compliance and R&D capacity building, according to the Index.

  • Takeda Named Global Top Employer for Fourth Consecutive Year
    Business Wire

    Takeda Named Global Top Employer for Fourth Consecutive Year

    Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) ("Takeda") today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receiving the global certification for the fourth consecutive year, Takeda was also certified as a Top Employer in four regions and 38 countries. This underscores the company’s commitment to creating an exceptional people experience for its global workforce.